XML 30 R18.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

9. Stock-based Compensation

2016 Long Term Incentive Plan – Our equity award grants during the periods presented below were granted under the 2016 Long Term Incentive Plan (the "2016 Plan"), which replaced the 2008 Incentive Stock Plan. The 2016 Plan was approved by our shareholders in 2016 and subsequently amended in 2021. No awards may be granted under the 2016 Plan on and after the tenth anniversary of its effective date. As of December 31, 2023, the maximum aggregate number of shares currently authorized for issuance under the 2016 Plan is 5,750,000 shares with 1,851,202 shares available to be issued. The 2016 Plan is administered by the compensation committee (the “Committee”) of our Board and allows for, among others, the following types of awards: restricted stock, restricted stock units, and other stock and cash-based awards, stock appreciation rights and stock options.

Restricted Stock and Restricted Stock Units During 2023, time-based restricted stock units ("RSU") and performance-based restricted stock units ("PBRSU") were granted to certain executives and employees. Certain time-based (i.e. a “service condition”) restricted stock units had graded vesting provisions of equal annual increments over three years while others had cliff vesting provisions of 100% at the end of three years. The PBRSUs granted in 2023 vest in three years and are based on a market condition. The equity awards granted in 2022 have similar vesting timeframes to those granted in 2023 while the PBRSUs granted in that year include units that vest based on a performance condition tied to the Company’s cost structure and units that vest based on a market condition. Details of the market and performance conditions are discussed further below.

During 2021, restricted stock and performance-based restricted stock were granted to certain executives and restricted stock units were granted to certain employees. Pursuant to the terms of the performance-based awards outstanding as of the change of control event associated with the exchange of the Series E and Series F Redeemable Preferred discussed in Note 1 – Summary of Significant Accounting Policies, additional shares of restricted stock were issued including the satisfaction of certain performance conditions above the target performance level. Also, such performance-based restricted stock subsequent to the change of control event, were thereafter subject only to the time-based vesting conditions set forth in the applicable award agreement and the 2016 Plan.

We generally grant RSUs to our non-employee directors annually. Vesting of our director grants occurs upon the earliest of: (i) the director’s separation from service, (ii) the first anniversary of the grant date, or (iii) the occurrence of a change of control, as defined by the agreement. Since the separation from service vesting provision effectively allows an award to vest with no minimum service requirement, these awards are fully expensed on the date they were granted. Pursuant to the terms of these RSU awards all of these RSU awards outstanding during 2021 immediately vested as a result of the change of control event discussed in Note 1 – Summary of Significant Accounting Policies.

A summary of equity award activity during 2023 is presented below:

 

 

 

Restricted Stock (1)

 

 

Performance-Based
Restricted Stock
(1)(2)

 

 

Restricted Stock Units

 

 

Performance Based Restricted Stock Units

 

 

 

Shares

 

 

Weighted-
Average
Grant Date
Fair Value

 

 

Shares

 

 

Weighted-
Average
Grant Date
Fair Value

 

 

Shares

 

 

Weighted-
Average
Grant Date
Fair Value

 

 

Shares

 

 

Weighted-
Average
Grant Date
Fair Value

 

Unvested outstanding beginning of year

 

 

546,494

 

 

$

2.72

 

 

 

312,639

 

 

$

2.71

 

 

 

422,447

 

 

$

10.50

 

 

 

161,922

 

 

$

10.40

 

Granted

 

 

 

 

$

 

 

 

 

 

$

 

 

 

442,116

 

 

$

10.87

 

 

 

171,641

 

 

$

20.62

 

Vested

 

 

(279,997

)

 

$

2.70

 

 

 

(170,244

)

 

$

2.69

 

 

 

(124,740

)

 

$

11.12

 

 

 

 

 

$

 

Cancelled or forfeited

 

 

 

 

$

 

 

 

 

 

$

 

 

 

(35,254

)

 

$

9.31

 

 

 

(4,329

)

 

$

16.78

 

Unvested outstanding end of year

 

 

266,497

 

 

$

2.73

 

 

 

142,395

 

 

$

2.73

 

 

 

704,569

 

 

$

10.33

 

 

 

329,234

 

 

$

17.03

 

Additional Information:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average fair value per stock/unit granted in 2022

 

 

 

 

$

 

 

 

 

 

$

 

 

 

 

 

$

13.15

 

 

 

 

 

$

13.22

 

Weighted-average fair value per stock/unit granted in 2021

 

 

 

 

$

3.55

 

 

 

 

 

$

3.09

 

 

 

 

 

$

5.05

 

 

 

 

 

$

 

 

 

 

 

 

Total Fair Value

 

 

Total Fair Value

 

 

Total Fair Value

 

 

Total Fair Value

 

 

 

In Thousands

 

Stock/unit vested in 2023

 

 

 

$

3,485

 

 

 

 

$

2,113

 

 

 

 

$

1,343

 

 

 

 

$

 

Stock/unit vested in 2022

 

 

 

$

4,394

 

 

 

 

$

4,976

 

 

 

 

$

 

 

 

 

$

 

Stock/unit vested in 2021

 

 

 

$

2,729

 

 

 

 

$

6,671

 

 

 

 

$

2,209

 

 

 

 

$

 

 

_____________________________

(1)
We did not grant any restricted stock or performance based restricted stock awards during 2023 or 2022.
(2)
Upon the change of control event associated with the exchange of the Series E and Series F Redeemable Preferred discussed in Note 1 – Summary of Significant Accounting Policies, during 2021 such PBRS are subject only to the time-based vesting conditions set forth in the applicable award agreement and the 2016 Plan.

The payout on our 2023 PBRSU grants, which vest in three years, is based on our total shareholder return feature (“TSR”) relative to our peer group. The vesting criteria is measured annually relative to annual targets (with a minimum threshold and a maximum ceiling) with a final adjustment in the third year. Each annual measurement results in a number of shares that are independently earned (i.e. “banked”) and are not affected by the measurement in the other periods. Banked shares are used in the final calculation to determine the vested shares at the end of the three-year period. As a result, the number of shares earned annually could be lower or higher than the annual target PRBSU shares. These awards granted require the grantee to be continuously employed through the end of the term for vesting purposes.

The 2022 PBRSU grants, which vest in three years, include units that vest based on a performance condition tied to the company’s cost structure and units that vest based on a market condition as measured by our TSR on an absolute basis. Both performance condition and market condition units are measured annually relative to annual targets for each respective criteria (with a minimum threshold and a maximum ceiling) with a final adjustment in the third year. Each annual measurement results in a number of shares that are independently earned (i.e. “banked") and are not affected by the measurement in the other periods. Banked shares are used in the final calculation to determine the vested shares at the end of the three-year period. As a result, the number of shares earned annually could be lower or higher than the annual target PRBSU shares. These awards granted require the grantee to be continuously employed through the end of the term for vesting purposes.

The fair value of our service condition and performance condition awards are based on the market price of our common stock.

We estimate the fair value of our market condition awards using a Monte Carlo simulation with the following assumptions:

the closing stock price on the day preceding the grant,
the prediction time horizon, the vesting term of the grant,
the three-year Treasury yield curve rate on the grant date,
the standard deviation of historical daily returns for the length of the vesting term of the grant.

 

 

 

Valuation Date

 

 

 

January 25, 2023

 

 

January 20, 2022

 

Valuation assumptions of market condition PBRSUs

 

 

 

 

 

 

Risk free rate

 

 

3.77

%

 

 

1.34

%

Volatility

 

 

95.06

%

 

 

97.92

%

Simulation period

 

2.93 years

 

 

2.92 years

 

Fair value

 

$

20.62

 

 

$

15.94

 

 

Stock Options – We have had no activity or stock-based compensation expense related to stock options during the past three years. As of December 31, 2023, we had 13,000 options at a weighted average exercise price of $25.66, all of which were out of the money and are scheduled to expire in 0.92 years.

Stock-based Compensation Expense – A summary of our stock-based compensation expense recognized and related income tax benefit for each of the three years we present our income statement is presented below:

 

 

Stock Based Compensation

 

 

 

2023

 

 

2022

 

 

2021

 

 

 

(In Thousands)

 

Stock-based compensation expense - Cost of sales

 

 

845

 

 

 

512

 

 

 

371

 

Stock-based compensation expense - SG&A

 

 

3,983

 

 

 

3,513

 

 

 

5,145

 

Income tax benefit

 

 

(1,128

)

 

 

(947

)

 

 

(1,355

)

As of December 31, 2023, unrecognized compensation cost related to outstanding awards was $6,597,000 with a weighted-average remaining vesting period of 1.7 years.